Cargando…

Plasma Amyloid Beta and Tau Levels Are Predictors of Post-stroke Cognitive Impairment: A Longitudinal Study

Objectives: Post-stroke cognitive impairment (PSCI) is a common disease that may occur within 3 months after a stroke or even later. However, the mechanism of PSCI development is unclear. The present study investigated whether the levels of plasma amyloid beta-42 (Aβ42) and tau are associated with t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chi, Nai-Fang, Chao, Shu-Ping, Huang, Li-Kai, Chan, Lung, Chen, Yih-Ru, Chiou, Hung-Yi, Hu, Chaur-Jong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614443/ https://www.ncbi.nlm.nih.gov/pubmed/31312178 http://dx.doi.org/10.3389/fneur.2019.00715

Ejemplares similares

Plasma Phosphorylated-tau181 Is a Predictor of Post-stroke Cognitive Impairment: A Longitudinal Study
por: Huang, Li-Kai, et al.
Publicado: (2022)

Prediction of Cerebral Amyloid Pathology Based on Plasma Amyloid and Tau Related Markers
por: Chen, Ting-Bin, et al.
Publicado: (2021)

Longitudinal Alterations of Alpha-Synuclein, Amyloid Beta, Total, and Phosphorylated Tau in Cerebrospinal Fluid and Correlations Between Their Changes in Parkinson's Disease
por: Dolatshahi, Mahsa, et al.
Publicado: (2018)

Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease
por: Melzer, Tracy R., et al.
Publicado: (2019)

Association Between Net Vertebral Artery Flow Volume and Non-AF Stroke: A Retrospective 2-Year Analysis
por: Lee, Hsun-Hua, et al.
Publicado: (2019)

Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles
por: Delaby, Constance, et al.
Publicado: (2022)

Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition
por: Risacher, Shannon L., et al.
Publicado: (2019)

Exploring How Low Oxygen Post Conditioning Improves Stroke-Induced Cognitive Impairment: A Consideration of Amyloid-Beta Loading and Other Mechanisms
por: Zhao, Zidan, et al.
Publicado: (2021)

Elevated Serum Amyloid A Is Associated With Cognitive Impairment in Ischemic Stroke Patients
por: Zhang, Yun, et al.
Publicado: (2022)

Cerebral Motor Functional Connectivity at the Acute Stage: An Outcome Predictor of Ischemic Stroke
por: Chi, Nai-Fang, et al.
Publicado: (2018)

Amyloid and tau PET in cerebral amyloid angiopathy-related inflammation two case reports and literature review
por: Yang, Jhih-Yong, et al.
Publicado: (2023)

Plasma p-tau181 Level Predicts Neurodegeneration and Progression to Alzheimer's Dementia: A Longitudinal Study
por: Wang, Yan-Li, et al.
Publicado: (2021)

Risk Factors for Postischemic Stroke Epilepsy in Young Adults: A Nationwide Population-Based Study in Taiwan
por: Do, Phuong Thao, et al.
Publicado: (2022)

Comparison of admission random glucose, fasting glucose, and glycated hemoglobin in predicting the neurological outcome of acute ischemic stroke: a retrospective study
por: Sung, Jia-Ying, et al.
Publicado: (2017)

Trunk Impairment as a Predictor of Activities of Daily Living in Acute Stroke
por: Ishiwatari, Masahiro, et al.
Publicado: (2021)

Serum amyloid A is a potential predictor of prognosis in acute ischemic stroke patients after intravenous thrombolysis
por: Chang, Qi, et al.
Publicado: (2023)

Transmission of amyloid-beta and tau pathologies is associated with cognitive impairments in a primate
por: Lam, Suzanne, et al.
Publicado: (2021)

Opinion: The Potential Role of Amyloid Beta Peptides as Biomarkers of Subconcussion and Concussion
por: Boutté, Angela M., et al.
Publicado: (2022)

Development and validation of risk score to estimate 1-year late poststroke epilepsy risk in ischemic stroke patients
por: Chi, Nai-Fang, et al.
Publicado: (2018)

Semantic intrusion errors are associated with plasma Ptau-181 among persons with amnestic mild cognitive impairment who are amyloid positive
por: Curiel Cid, Rosie E., et al.
Publicado: (2023)

Roles of Microglial and Monocyte Chemokines and Their Receptors in Regulating Alzheimer's Disease-Associated Amyloid-β and Tau Pathologies
por: Guedes, Joana R., et al.
Publicado: (2018)

Tau and Amyloid-β Peptides in Serum of Patients With Parkinson's Disease: Correlations With CSF Levels and Clinical Parameters
por: Schirinzi, Tommaso, et al.
Publicado: (2022)

Clinical, imaging, and biomarker evidence of amyloid- and tau-related neurodegeneration in late-onset epilepsy of unknown etiology
por: Hickman, L. Brian, et al.
Publicado: (2023)

The Correlations Between Plasma Fibrinogen With Amyloid-Beta and Tau Levels in Patients With Alzheimer’s Disease
por: Fan, Dong-Yu, et al.
Publicado: (2021)

Plasma amyloid-beta oligomer and phosphorylated tau: diagnostic tools for progressive Alzheimer’s disease
por: An, Seong Soo A., et al.
Publicado: (2023)

CSF p-tau as a potential cognition impairment biomarker in ALS
por: Gong, Zhongying, et al.
Publicado: (2022)

Platelet and Plasma Phosphatidylcholines as Biomarkers to Diagnose Cerebral Amyloid Angiopathy
por: Foidl, Bettina M., et al.
Publicado: (2020)

Amyloid Beta Oligomers Target to Extracellular and Intracellular Neuronal Synaptic Proteins in Alzheimer's Disease
por: Ding, Yu, et al.
Publicado: (2019)

Anxiety and Levodopa Equivalent Daily Dose Are Potential Predictors of Sleep Quality in Patients With Parkinson Disease in Taiwan
por: Chang, Chun-Wei, et al.
Publicado: (2019)

Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative Data
por: Bos, Isabelle, et al.
Publicado: (2018)

Associations of estradiol levels and genetic polymorphisms of inflammatory genes with the risk of ischemic stroke
por: Hsieh, Yi-Chen, et al.
Publicado: (2017)

Sensory Impairment and Beta-Amyloid Deposition in the Baltimore Longitudinal Study of Aging
por: Armstrong, Nicole, et al.
Publicado: (2021)

Sensory impairment and beta‐amyloid deposition in the Baltimore longitudinal study of aging
por: Yesantharao, Lekha, et al.
Publicado: (2023)

Cognitive Impairment After Stroke
por: Renjen, Pushpendra Nath, et al.
Publicado: (2015)

Osmotin attenuates amyloid beta-induced memory impairment, tau phosphorylation and neurodegeneration in the mouse hippocampus
por: Ali, Tahir, et al.
Publicado: (2015)

Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease
por: Chang, Chun-Wei, et al.
Publicado: (2020)

Case report: Non-Alzheimer's disease tauopathy with logopenic variant primary progressive aphasia diagnosed using amyloid and tau PET
por: Momota, Yuki, et al.
Publicado: (2022)

Expression of Cytokines and Chemokines as Predictors of Stroke Outcomes in Acute Ischemic Stroke
por: Martha, Sarah R., et al.
Publicado: (2020)

Overpressure Exposure From .50-Caliber Rifle Training Is Associated With Increased Amyloid Beta Peptides in Serum
por: Thangavelu, Bharani, et al.
Publicado: (2020)

Use of Zebrafish Genetic Models to Study Etiology of the Amyloid-Beta and Neurofibrillary Tangle Pathways in Alzheimer's Disease
por: Kiper, Keturah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2nmr314odpn0en83msvf449707